- Evolving Cancer Classification in the Era of Personalized Medicine: A Primer for Radiologists
-
O'Neill AC, Jagannathan JP, Ramaiya NH
- KMID: 2468118
- Korean J Radiol.
- 2017 Feb;18(1):6-17.
- doi: 10.3348/kjr.2017.18.1.6
Traditionally tumors were classified based on anatomic location but now specific genetic mutations in cancers are leading to treatment of tumors with molecular targeted therapies. This has led to a... -
- CITED
-
- Close
- SHARE
-
- Close
- Immune checkpoint blockade therapy for bladder cancer treatment
-
Kim J
- KMID: 2426521
- Investig Clin Urol.
- 2016 Jun;57(Suppl 1):S98-S105.
- doi: 10.4111/icu.2016.57.S1.S98
Bladder cancer remains the most immunogenic and expensive malignant tumor in the United States today. As the 4th leading cause of death from cancer in United States, Immunotherapy blocking immune... -
- CITED
-
- Close
- SHARE
-
- Close
- Systemic Chemotherapy in Advanced Pancreatic Cancer
-
Lee HS, Park SW
- KMID: 2411959
- Gut Liver.
- 2016 May;10(3):340-347.
- doi: 10.5009/gnl15465
Pancreatic cancer remains one of the most lethal cancers. These patients often have multiple symptoms, and integrated supportive care is critical in helping them remain well for as long as... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic options for management of endometrial hyperplasia
-
Chandra V, Kim JJ, Benbrook D, Dwivedi A, Rai R
- KMID: 2360238
- J Gynecol Oncol.
- 2016 Jan;27(1):e8.
- doi: 10.3802/jgo.2016.27.e8
Endometrial hyperplasia (EH) comprises a spectrum of changes in the endometrium ranging from a slightly disordered pattern that exaggerates the alterations seen in the late proliferative phase of the menstrual... -
- CITED
-
- Close
- SHARE
-
- Close
- Drug therapy of overactive bladder - What is coming next?
-
Andersson
- KMID: 2344109
- Korean J Urol.
- 2015 Oct;56(10):673-679.
- doi: 10.4111/kju.2015.56.10.673
After the approval and introduction of mirabegron, tadalafil, and botulinum toxin A for treatment of lower urinary tract symptoms/overactive bladder, focus of interest has been on their place in therapy... -
- CITED
-
- Close
- SHARE
-
- Close
- Trastuzumab-Conjugated Liposome-Coated Fluorescent Magnetic Nanoparticles to Target Breast Cancer
-
Jang M, Yoon YI, Kwon YS, Yoon TJ, Lee HJ, Hwang SI, Yun BL, Kim SM
- KMID: 1731043
- Korean J Radiol.
- 2014 Aug;15(4):411-422.
- doi: 10.3348/kjr.2014.15.4.411
OBJECTIVE: To synthesize mesoporous silica-core-shell magnetic nanoparticles (MNPs) encapsulated by liposomes (Lipo [MNP@m-SiO2]) in order to enhance their stability, allow them to be used in any buffer solution, and to... -
- CITED
-
- Close
- SHARE
-
- Close
- APE1/Ref-1 as an emerging therapeutic target for various human diseases: phytochemical modulation of its functions
-
Thakur S, Sarkar B, Cholia RP, Gautam N, Dhiman M, Mantha AK
- KMID: 2155371
- Exp Mol Med.
- 2014 Jul;46(7):e106.
- doi: 10.1038/emm.2014.42
Apurinic/apyrimidinic endonuclease 1 (APE1) is a multifunctional enzyme involved in the base excision repair (BER) pathway, which repairs oxidative base damage caused by endogenous and exogenous agents. APE1 acts as... -
- CITED
-
- Close
- SHARE
-
- Close
